Yale Podnos

Companies

• Starling Oncology, Inc.Chief Medical Officer Nov 16, 2021 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SOStarling Oncology, Inc. STLN259,527 shares²$1.7M at $6.53Jul 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 14, 2026Sold 5,478 shares at $6.35 of Starling Oncology, Inc.²
• Jul 14, 2026Exercised options 5,478 shares at $2.00 of Starling Oncology, Inc.²
• Jul 14, 2026Sold 17,974 shares at $6.43 of Starling Oncology, Inc.²
• Jul 14, 2026Exercised options 17,974 shares at $1.87 of Starling Oncology, Inc.²
• Jun 8, 2026Sold 23,451 shares at $5.38 of Starling Oncology, Inc.³
• May 21, 2026Other 1,805 shares at $4.47 of Starling Oncology, Inc.⁴
• Mar 27, 2026Other 16,173 shares at $3.07 of Starling Oncology, Inc.⁵
• Mar 27, 2026Granted 66,446 shares of Starling Oncology, Inc.⁵
• Mar 17, 2026Other 3,420 shares at $3.59 of Starling Oncology, Inc.⁶
• Nov 17, 2025Granted 2,086 shares of Starling Oncology, Inc.⁷
• Nov 12, 2025Granted 1,202 shares of Starling Oncology, Inc.⁸
• Nov 12, 2025Granted 306 shares of Starling Oncology, Inc.⁸
• May 21, 2025Returned to company 1,801 shares at $2.68 of Starling Oncology, Inc.⁹
• Mar 31, 2025Granted 157,088 shares of Starling Oncology, Inc.¹⁰
• Mar 26, 2025Bought 9,056 shares at $1.04 of Starling Oncology, Inc.¹¹
• Mar 19, 2025Returned to company 2,975 shares at $0.89 of Starling Oncology, Inc.¹²
• Nov 20, 2024Returned to company 1,026 shares at $0.14 of Starling Oncology, Inc.¹³
• Nov 20, 2024Returned to company 267 shares at $0.14 of Starling Oncology, Inc.¹³
• Nov 20, 2024Returned to company 1,709 shares at $0.14 of Starling Oncology, Inc.¹³
• Nov 12, 2024Other 17,039 shares of Starling Oncology, Inc.¹⁴
• Nov 12, 2024Other 11,359 shares of Starling Oncology, Inc.¹⁴
• May 21, 2024Granted 17,530 shares of Starling Oncology, Inc.¹⁵
• Nov 21, 2023Returned to company 1,530 shares at $2.19 of Starling Oncology, Inc.¹⁶
• Nov 14, 2023Returned to company 1,860 shares at $2.39 of Starling Oncology, Inc.¹⁷
• Nov 14, 2023Returned to company 238 shares at $2.39 of Starling Oncology, Inc.¹⁷